| Top 50 Most Viewed Posts Last Month |
|---|
|
Today This Week Last Week This Month Last Month
|
1. KenChowder: For what it's worth, Dr. Max Lataillade is not (3909)  (23) |
| 2. ohm20: It looks like Leronlimab will compliment (2731) (25) |
| 3. Jake2212: " Syneos Health has helped to develop or (2724) (24) |
| 4. My69z: Max/GSK/FDA/Fostemsavir: Meeting Category: (2338) (18) |
| 5. My69z: Consider this: Dr. Lataillade hiring; Nov. 2023 (2274) (10) |
| 6. Goodspeed65: I'm a believer!! I believe we got (2099) (2) |
| 7. Katangolo: Love seeing us partnering. Little CYDY is growing (1981) (12) |
| 8. biloxiblues: I think everything hinges on what comes back from (1967) (14) |
| 9. Jake2212: Perhaps TAK, not MRK, lies in LL's future. We all (1965) (32) |
| 10. mightycydy: Re: CYDY's new hire - Dr. Max Lataillade Video (1779) (8) |
| 11. My69z: Gaudinski / GSK / VRC07-523LS: 2019 Pi on (1722) (6) |
| 12. ohm20: Leronlimab - Disease List (currently 90) (updated (1311) (28) |
| 13. MJS719: It looks like Leronlimab will compliment (1311) (17) |
| 14. Biolyfe: Board of directors. So to Jump Right In, I'll (1225) (23) |
| 15. Albert364: Love International Group, Inc. (LOVV) is a (1166) |
| 16. SporadicE: Ohm20 opined, "My mind is spinning in circles (977) (11) |
| 17. KenChowder: Great that 5000 girls and young women did not (959) (8) |
| 18. testuser: A Agilent Technologies AA Alcoa Inc. AAN Aaron's (954) |
| 19. MGK_2: So, in the experiment, they took 4 monkeys (949) (14) |
| 20. Figgs: Ever since I got my job as a lobbyist for Gilead (919) (6) |
| 21. ohm20: would a Phase III that repeats the Phase II be (905) (13) |
| 22. z_smith01: As we have discussed in the past, any Paulson (904) (35) |
| 23. KenChowder: I may not be reading the abstract right. Yes, (897) (13) |
| 24. docj: Short interest is barely over 1% hoops. I think (878) (5) |
| 25. sean007: I'm sure this is not lost... on our friends at (874) (6) |
| 26. biloxiblues: From Reddit Four papers out - again upwards (861) (4) |
| 27. Chasing Stars: Getting started on Investors Hangout. Are you (860) (14) |
| 28. brentie: Article in the Columbian, nothing too exciting (858) (12) |
| 29. My69z: With $24m @ 8/31/2024: Below has occurred since (853) (18) |
| 30. Katangolo: I saw a post on Reddit (sunraydoc) and even (845) (31) |
| 31. ohm20: It's absolutely an impediment to raising funds (835) (33) |
| 32. sean007: I just have to share this: (826) (3) |
| 33. biloxiblues: I have been with CYDY since 2011, and I can tell (822) (14) |
| 34. Katangolo: I read your latest post over on reddit. Nice (814) (26) |
| 35. sean007: Check with My69z...most recent...all broken (805) (3) |
| 36. My69z: Lalezari/Deeks/Martin: The SCOPE cohort is (796) (3) |
| 37. My69z: It's autocorrect!!...hahaaa Yea...but she's not (789) (2) |
| 38. My69z: Long Covid results -- 4/2024. Submitted 586 days (783) (7) |
| 39. docj: I sent a respectful email about this to: Media (781) (8) |
| 40. Buddyboy20: Another one bites the dust, in MASH gamble. (780) (3) |
| 41. My69z: GSK owns 27% Samsung Bio. (780) (13) |
| 42. Katangolo: The evolutionary advantage being that it produces (762) (2) |
| 43. Respert24: If they do decide to announce the protocol for (760) (18) |
| 44. My69z: Kat, you said: " But ViiV Got its hands on (748) (4) |
| 45. sean007: It's been said,...hundreds of times...in the last (743) (2) |
| 46. biloxiblues: I am not sure if this has been posted, but I saw (733) (16) |
| 47. Charter2024: Its posts like this one that gives me hope again (728) (6) |
| 48. ohm20: Interesting mouse study in Glioblastoma. A cheap (723) (24) |
| 49. mightycydy: CYDY's Dr. Jonah Sacha & amFAR "New amfAR grants (718) (15) |
| 50. sean007: There are far too many knowledgeable PhD's and (711) (6) |
